Fortress Biotech (FBIO) and Synlogic (SYBX) Financial Survey


Synlogic and Fortress Biotech are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation and institutional ownership. Synlogic currently has a consensus price target of $18.75, suggesting a potential upside of 88.44%.



from Biotech News